Artwork

The Good GP에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 The Good GP 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Understanding the Intricacies of LFTs in Clinical Practice with Dr Chanika Ariyawansa

18:34
 
공유
 

Manage episode 420602940 series 3296340
The Good GP에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 The Good GP 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

In this episode of The Good GP, hosts Dr Sean Stevens and Dr Tim Koh are joined by Dr Chanika Ariyawansa, a WA-trained chemical pathologist with additional training in genetic pathology. Dr Ariyawansa, who holds significant roles in the Australian Association of Clinical Biochemistry, delves into the nuances of liver function tests (LFTs), exploring patterns and implications of abnormal results.

Firstly, with an examination of the prevalence and general patterns of abnormal LFTs, highlighting the commonality of mild and transient abnormalities. Dr Ariyawansa clarifies common misconceptions regarding LFTs, emphasising that not all markers in the standard LFT panel are liver-specific or directly assess liver function.

They also explain in detail individual LFT components such as bilirubin, ALP, GGT, AST, and ALT. The guest expert also categorises potential abnormalities into hepatocellular, cholestatic, mixed, and non-hepatic causes, with practical insights on each. Special attention is given to non-hepatic causes, analytical causes, and how these might influence LFT interpretation.

Dr Ariyawansa's expertise shines as she discusses managing patient anxiety around abnormal LFT results and the practical aspects of educating patients about their liver health. She stresses the utility of resources such as the Pathology Tests Explained website for patient education.

Wrapping up with an engaging Q&A session addressing specific scenarios like non-drinking patients with isolated raised GGT and the impact of statins on LFTs. She answers with clinical relevance, offering listeners practical strategies for understanding and communicating complex test results in their practice.

The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com.

Mentioned in this episode:

Proudly supported by Medtech Global:

The Good GP Podcast is sponsored by Medtech Global, they help GPs be GPs by working with clinicians in Australia and New Zealand to develop Patient Management Systems and healthcare technology. Visit the link for more information:

Medtech Global

  continue reading

172 에피소드

Artwork
icon공유
 
Manage episode 420602940 series 3296340
The Good GP에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 The Good GP 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

In this episode of The Good GP, hosts Dr Sean Stevens and Dr Tim Koh are joined by Dr Chanika Ariyawansa, a WA-trained chemical pathologist with additional training in genetic pathology. Dr Ariyawansa, who holds significant roles in the Australian Association of Clinical Biochemistry, delves into the nuances of liver function tests (LFTs), exploring patterns and implications of abnormal results.

Firstly, with an examination of the prevalence and general patterns of abnormal LFTs, highlighting the commonality of mild and transient abnormalities. Dr Ariyawansa clarifies common misconceptions regarding LFTs, emphasising that not all markers in the standard LFT panel are liver-specific or directly assess liver function.

They also explain in detail individual LFT components such as bilirubin, ALP, GGT, AST, and ALT. The guest expert also categorises potential abnormalities into hepatocellular, cholestatic, mixed, and non-hepatic causes, with practical insights on each. Special attention is given to non-hepatic causes, analytical causes, and how these might influence LFT interpretation.

Dr Ariyawansa's expertise shines as she discusses managing patient anxiety around abnormal LFT results and the practical aspects of educating patients about their liver health. She stresses the utility of resources such as the Pathology Tests Explained website for patient education.

Wrapping up with an engaging Q&A session addressing specific scenarios like non-drinking patients with isolated raised GGT and the impact of statins on LFTs. She answers with clinical relevance, offering listeners practical strategies for understanding and communicating complex test results in their practice.

The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com.

Mentioned in this episode:

Proudly supported by Medtech Global:

The Good GP Podcast is sponsored by Medtech Global, they help GPs be GPs by working with clinicians in Australia and New Zealand to develop Patient Management Systems and healthcare technology. Visit the link for more information:

Medtech Global

  continue reading

172 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드